| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |